Neupogen G-CSF data

Two separate studies of Neupogen published in The New England Journal of Medicine produced mixed results on the clinical utility of the drug in certain settings (see Noteworthy, BioCentury Part I).

Mayo Clinic researchers (Rochester, Minn.) and colleagues published a randomized, double-blind, placebo-controlled trial

Read the full 440 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE